Sumanta (Monty) Pal, MD, FASCO, Professor, Department of Medical Oncology & Therapeutics Research and Co-director, Kidney Cancer Program at City…
Browsing: Urology
Sumanta (Monty) Pal, MD, FASCO, Professor, Department of Medical Oncology & Therapeutics Research and Co-director, Kidney Cancer Program at City…
Petros Grivas, MD, PhD Seattle Cancer Care Alliance discusses FDA Approves Avelumab (BAVENCIO) as First-Line Maintenance Treatment for Patients with…
Shilpa Gupta, MD – Cleveland Clinic discusses Perioperative Novel Systemic Immunotherapy-Based Approaches in Urinary Cancers – Abstract 5019 and Abstract…
Seth Lerner, MD of Baylor College of Medicine @bcmhouston discusses the innovative approach option for treating upper tract urothelial cancer.…
Seth Lerner, MD of Baylor College of Medicine @bcmhouston discusses the innovative approach option for treating upper tract urothelial cancer.…
Seth Lerner, MD of Baylor College of Medicine @bcmhouston discusses the innovative approach option for treating upper tract urothelial cancer.…
Thomas Powles, MD, MBBS @tompowles1 of @QMBCI discusses how the JAVELIN study affects clinicians and treatment today.
Thomas Powles, MD, MBBS @tompowles1 of @QMBCI answers common questions regarding the JAVELIN study including what happens to patients with…
Thomas Powles, MD, MBBS @tompowles1 of @QMBCI explains the phase III JAVELIN study in urothelial cancer.
Matthew Galsky, MD, Director of Genitourinary Medical Oncology At The Tisch Cancer Institute at Mount Sinai Discusses HCRN GU14-182: Randomized…
Matthew Galsky, MD, Director of Genitourinary Medical Oncology At The Tisch Cancer Institute at Mount Sinai Discusses HCRN GU14-182 Questions:…
From the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA, Elizabeth Plimack, MD, from Fox Chase Cancer Center, Philadelphia,…
In this video, Elizabeth Plimack, MD, from Fox Chase Cancer Center, Philadelphia, PA, discusses the progress made in prostate, bladder…
Results from clinical trials determine the effectiveness, toxicity and, ultimately, the approval of novel therapies for cancer. Here, Gregory Pond,…
Urothelial carcinoma has been a challenge for oncologists to treat for many years, with a steady mortality rate and no…